Erlonat (erlotinib) is principally used to treat cell lung malignancy, or pancreatic growth when joined with a specific other prescription. It works by restraining development to nearby tissues in the body with the goal that the malignant cells back off, permitting the patient a superior domain to recuperate and battle the tumor normally.
Dosages and administration :
Erlonat contains erlotinib and has a place with a class of prescriptions called kinase inhibitors.
Utilized for :
Erlonat is utilized for the treatment of non-little cell lung tumor. Erlonat is utilized as a part of blend with gemcitabine for the treatment of pancreatic growth that has spread to adjacent tissues or to different parts of the body.
Produced By : NATCO
Product Name : | Erlonat |
Contains : | Erlotinib hydrochloride |
Form : | Tablet |
Strength : | 100 mg & 150 mg |
Packing : | Pack Of 30 Tabs |
Price: